Sources of infection. by Jesús Poch-Páez (21807825)

Subjects:

Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

“…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”

Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

“…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”

Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

“…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”

Demographics and clinical characteristics. by Marin Jacobwitz (22001673)

Comparison between pre-dialysis and dialysis groups regarding clinical features and biological findings. by Arwa Yahyaoui (22683276)

Subjects:

Gene network of significantly enriched KEGG pathway. by Chae Won Lee (14957165)

Uncertain significance copy number variations found in fetuses by SNP array. by Li Wen (169316)

Subjects:

Description of clinical characteristics of the study population, by gender. by Syed Irfan Karim (10701427)

ELISA analysis revealed a significant decrease in SP (A & B) and CGRP (C & D) protein levels in the corneas and tear fluid of mice treated with 0.5% bupivacaine (BUP) every alternate day for 15 days (administered via subconjunctival injection (SCI) alone or in combination with topical (TOP) application) compared to PBS-treated controls. by Ananya Datta (19932144)

Time Course of the RAAS. by Ningning Wang (560944)

Subjects:

Clinical outcomes of participants challenged with ETEC. by Xueyan Zhang (277449)

Forest plot of CMS clinical score. by Yaqin Wang (188672)

Subjects:

The significantly enriched pathways in the high group compared with the low group. by Bo Zhao (13553)

Responses to six specific statements regarding causes of oral diseases by ethnicity. by Lutango D. Simangwa (22755650)

Autosomal dominant polycystic kidney disease: an overview of recent genetic and clinical advances by Abdul Hamid Borghol (21338636)

“…The Mayo Imaging Classification is currently the most practical tool for predicting rate of kidney disease progression in ADPKD. This review provides a comprehensive overview of ADPKD, focusing on its genetics, pathophysiology, clinical presentation, management, and prognostic tools. …”

COX regression analysis for 3-year clinical outcomes. by Huimin Xian (20390006)

Cumulative incidence plots for 3-year clinical outcomes. by Huimin Xian (20390006)

The (A) logistic regression model (LRM) and (B) random forest model (RFM) with only conservation scores as independent variables (orange, yellow) show decreased model fitting metri... by Bushra Haque (20513785)

Nomogram for Predicting Prognosis in Initial Dialysis Patients with Chronic Kidney Disease Based on P-CONUT and Clinical Variables. by Xing Li (134367)